Cipro and a black box warning. The FDA requires a black box warning on Cipro (ciprofloxacin hydrochloride) and other fluoroquinolone
Use of ciprofloxacin for acute sinusitis,AECB and acute uncomplicated UTIsshould be avoided due recent FDA warning (Boxed warning) regarding
Use of ciprofloxacin for acute sinusitis,AECB and acute uncomplicated UTIsshould be avoided due recent FDA warning (Boxed warning) regarding
Cipro and a black box warning. The FDA requires a black box warning on Cipro (ciprofloxacin hydrochloride) and other fluoroquinolone
at or FDA at . FDA-1088 or www.fda.gov/medwatch. ciprofloxacin therapy [see Warnings and. Precautions (5.13) and Use in
In 2024, the FDA warned the public that ciprofloxacin and other fluoroquinolone antibiotics can cause tendon inflammation and rupture. They issued a boxed warning (the FDA s strongest medication warning) for this risk. The risk of tendon inflammation is highest the first month after taking ciprofloxacin. Other risk factors include being of
FDA-approved fluoroquinolones include levofloxacin (Levaquin), ciprofloxacin (Cipro) Warnings and Precautions section of the drug
Use of ciprofloxacin for acute sinusitis,AECB and acute uncomplicated UTIsshould be avoided due recent FDA warning (Boxed warning) regarding
at or FDA at 1. 800-FDA-1088 or www.fda.gov/medwatch. ciprofloxacin therapy [see Warnings and. Precautions (5.12) and Use in
Comments
What the hell would the FDA have to do with it? This is a piece of machinery. They would have NO say about it whatsoever.
Good story - would like to see more!
Do you realize the world doesn't end at USA borders?